Aβ and 22C11 agonist decreased cholesterol uptake whereas the sAPP-derived peptide and SM-ϕ stimulated increased cholesterol uptake by Caco-2 cells. by Kendra L. Puig (334788)

Decreasing risk of an unvaccinated badger cub testing positive to a triple diagnostic test for <i>M. bovis</i> infection as the proportion of vaccinated badgers in its social group increases. by Stephen P. Carter (112199)

Treatment with a highly reducing agent decreases ubiquitination of D_4.2R WT and D_{4.2 4KR}R mutant. by Kamila Skieterska (841014)

Omeprazole (Ome) decreases IL-4-stimulated RNA Pol II binding to the endogenous eotaxin-3 promoter in (A) EoE1-T and (B) EoE2-T cells. by Xi Zhang (83736)

Genes with a decreased level of expression both in wild-type strains treated with H₂O₂ (20 mM) and in MOxyR. by Huan Chen (6545)

(Figure A) Decreased acetylation of histone H4K16 was observed in the presence of As₂O₃ HeLa or HEK293T cells. by Da Liu (462193)

Reduced cellular glucose uptake in response to insulin and decreased expression of a mitochondrial ETC complex subunit in <i>ALAS1</i>-knockdown C2C12 myocytes. by Shinichi Saitoh (4794345)

Knockout of the <i>ypfP</i>, <i>ltaA</i>, and <i>tagO</i> genes decreases <i>S</i>. <i>aureus</i> aggregation in silkworm plasma. by Hiroki Ryuno (6755906)

The scientific community’s tradition decreases risk-taking and effort away from their productivity-maximizing actions in a richer model in which effort also affects the probability distribution of publishable results. by Kevin Gross (637614)

Decreased peritumoral myofibroblasts in the MC38 S.C. tumors of <i>S100a4-Cre; Ext1</i>^<i>f/f</i> mice. by Ayumi Niwa (6256790)

Conditions represented from the “other skin and subcutaneous diseases” Global Burden of Diseases category in the NIAMS 2013 skin-focused grants^a (arranged in order of decreasing funding). by Chante Karimkhani (594512)

Treatment with SEFA-6179 in mice receiving a high carbohydrate diet (HCD) with intravenous saline or SOLE decreases lipid metabolites involved in lipotoxicity including diacylglycerol, triglycerides, cholesterol, and ceramides. by Bennet S. Cho (6944669)

<i>Nf1</i> OPG mice show decreased spontaneous alternations in a Y-maze but no deficits in spatial working memory or long-term depression (LTD) in hippocampal slices. by David F. Wozniak (78177)

Decreasing rates of disorganised attachment in infants and young children, who are at risk of developing, or who already have disorganised attachment. A systematic review and meta-analysis of early parenting interventions by Barry Wright (313307)

Data_Sheet_1_Low molecular weight heparin decreases mortality and major complication rates in moderately severe and severe acute pancreatitis–a systematic review and meta-analysis.docx by Cristina Patoni (16619856)

“…Randomized controlled trials (RCTs) and observational studies that reported the differences in the outcomes of AP for patients receiving anticoagulants (intervention group) in addition to the standard of care (SOC), compared to patients managed by SOC alone (control group), were eligible. A random-effects model was used to calculate the pooled odds ratios (OR) and mean differences (MD) with the corresponding 95%-confidence intervals (CI). …”

Decreased intracellular replication of <i>S</i>. Typhimurium Δ<i>sucCD</i> and Δ<i>gltA</i> strains during infection of HeLa epithelial cells. by Steven D. Bowden (237943)

Evolutionary dynamics of replicators’ association rate without and with parasites: <i>k</i>_<i>a</i> decreases in the absence of parasites, and evolves to higher values the stronger the parasites. by Enrico Sandro Colizzi (2633266)

Table_1_YTHDF2 Gene rs3738067 A>G Polymorphism Decreases Neuroblastoma Risk in Chinese Children: Evidence From an Eight-Center Case-Control Study.DOC by Huijuan Zeng (6637514)

“…We found that the rs3738067 A>G could decrease neuroblastoma risk [AG vs. AA: adjusted odds ratio (OR) = 0.76, 95% confidence interval (CI) = 0.64–0.90, P = 0.002; AG/GG vs. …”

Identification of a Novel Protein Phosphatase 2A Activator, PPA24, as a Potential Therapeutic for FOLFOX-Resistant Colorectal Cancer by Hannah Johnson (1342596)

“…A series of compounds were designed utilizing molecular modeling and fragment-based design based upon the known protein phosphatase 2A (PP2A) activators, <b>NSC49L</b> and <b>iHAP1</b>, and evaluated for their ability to inhibit the viability of colorectal cancer (CRC) and folinic acid, 5-fluorouracil, and oxaliplatin (FOLFOX)-resistant CRC cells. …”

Phenotypic diversity and drug susceptibility of <i>Trypanosoma cruzi</i> TcV clinical isolates by Luz P. Quebrada Palacio (613253)

“…Benznidazole-resistant BOL-FC10A epimastigotes had decreased expression of Old Yellow Enzyme and cytosolic superoxide dismutase, and overexpression of mitochondrial superoxide dismutase and tryparedoxin- 1, compared to benznidazole-susceptible AR-SE23C parasites. …”